Skip to main content

Table 3 Multivariate analysis of risk factors of EFS and OS of DLBCL patients treated with CHOP

From: P38 MAPK expression and activation predicts failure of response to CHOP in patients with Diffuse Large B-Cell Lymphoma

 

Relative risk

95 % Cl

P

EFS

   

 P-p38+

2.54

1.01–6.4

<0.05

 Bcl-2+

2.26

1.04–7.21

<0.05

 ABC

1.69

1.07–3.63

<0.05

OS

   

 P-p38+

2.93

1.13–7.5

<0.05

 Bcl-2+

3.33

1.28–6.63

<0.05

 ABC

2.45

1.68–4.56

<0.05

  1. Cl Confidence intervals, EFS event-free survival, OS overall survival
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us